The invasive emerald ash borer, according to the U.S. Department of Agriculture, was first found in the United States in ...

SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company, today ...

A new study on mice shows that luck in early life can determine success as an adult, especially when competition is high.

Discover the significance of C. elegans in biological research, from Nobel Prize-winning discoveries to insights into gene ...

The holy grail of pandemic preparedness is being able to predict how a virus will evolve just by looking at its genetic ...

Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populatio | ...

Variant Bio, a genomics-driven drug discovery company, today announced a multi-year research collaboration with Novo Nordisk to discover novel targets for the treatment of metabolic disease.

The study highlights T2-low and T17-high asthma endotypes in minoritized youths, offering insights for precision medicine and ...